GlobeNewswire Inc.··Na4DMT to Present Pipeline Progress at Three Major Healthcare Conferences
4DMT will present pipeline progress at three major healthcare conferences in March 2026, showcasing late-stage programs including 4D-150 for retinal disease and 4D-710 for cystic fibrosis.
FDMTPhase 3 clinical trialinvestor conference